Cerulenin-induced changes in the lipopolysaccharide content and phospholipid composition of Proteus mirabilis.
Inhibition of Proteus mirabilis growth by cerulenin, a specific inhibitor of fatty acid biosynthesis, was reversed by exogenously supplied fatty acid mixtures containing oleic acid and palmitic or pentadecanoic acids. The growth rate of the cells treated with cerulenin in the presence of the fatty acid mixtures was slower, however, than that of untreated cells, and their lipopolysaccharide content was decreased by 30-50%, resulting in an increased sensitivity of the organisms to rifamycin and vancomycin. Polyacrylamide gel electrophoresis of the lipopolysaccharide fraction from cerulenin-treated cells revealed that of the two P. mirabilis lipopolysaccharide types, the relative amount of the higher molecular weight lipopolysaccharide was reduced from 50% to 30% of the total lipopolysaccharide. Fatty acid analysis of the phospholipid and lipopolysaccharide fractions from cells grown with cerulenin, pentadecanoate, and oleate revealed that over 60% of the native even-numbered fatty acids of the phospholipid fraction was substituted by the odd-numbered fatty acid, while no incorporation of either the pentadecanoate or oleate could be demonstrated in the lipid A moiety of the lipopolysaccharide. The only change in the lipid A observed was an increase in the content of 3-hydroxymyristic acid accompanied by a decrease in the nonhydroxylated fatty acids, supporting the highly conserved nature of this molecule.
D000935:Antifungal Agents / Q000494:pharmacology*; D002569:Cerulenin / Q000494:pharmacology*; D007700:Kinetics; D008070:Lipopolysaccharides / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D011135:Polysaccharides, Bacterial / Q000378:metabolism*; D011513:Proteus mirabilis / Q000187:drug effects / Q000378:metabolism*; D012294:Rifamycins / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000935:Antifungal Agents; D008070:Lipopolysaccharides; D010743:Phospholipids; D011135:Polysaccharides, Bacterial; D012294:Rifamycins; D002569:Cerulenin; D014640:Vancomycin